Literature DB >> 1854181

Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam.

M L van Ogtrop1, H F Guiot, H Mattie, E van Strijen, B R Sekh, R van Furth.   

Abstract

Oral and parenteral administration of aztreonam and oral administration of tigemonam to conventional mice caused a decrease in the number of aerobic gram-negative rods in the feces. Oral treatment with high doses of aztreonam (greater than or equal to 25 mg/kg/day) and tigemonam (100 mg/kg/day) adversely influenced colonization resistance, whereas oral treatment with lower doses of the monobactams or parenteral treatment with aztreonam did not.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854181      PMCID: PMC245140          DOI: 10.1128/AAC.35.5.983

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.

Authors:  M L van Ogtrop; H Mattie; H F Guiot; E van Strijen; B R Sekh; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins.

Authors:  M L van Ogtrop; H F Guiot; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers.

Authors:  G W Welling; G Groen; S Welling-Wester; H G de Vries-Hospers; D van der Waaij
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

4.  In vivo evaluation of tigemonam, a novel oral monobactam.

Authors:  J M Clark; S J Olsen; D S Weinberg; M Dalvi; R R Whitney; D P Bonner; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

5.  Aztreonam therapy in neutropenic patients with cancer.

Authors:  P G Jones; K V Rolston; V Fainstein; L Elting; R S Walters; G P Bodey
Journal:  Am J Med       Date:  1986-08       Impact factor: 4.965

6.  Effect of aztreonam on throat and stool flora of cancer patients.

Authors:  P G Jones; G P Bodey; E A Swabb; B Rosenbaum
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

7.  Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers.

Authors:  H G de Vries-Hospers; G W Welling; E A Swabb; D van der Waaij
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

8.  Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans.

Authors:  M Giuliano; M Barza; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge.

Authors:  L M Pope; G T Cole; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

10.  Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans.

Authors:  M Barza; M Giuliano; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

View more
  2 in total

1.  Microbiome as mediator: Do systemic infections start in the gut?

Authors:  Melissa Latorre; Suneeta Krishnareddy; Daniel E Freedberg
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 2.  Selective decontamination in bone marrow transplant recipients.

Authors:  H F Guiot; R van Furth
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.